Literature DB >> 8693702

The vasomotor effects of 5-hydroxytryptamine on equine basilar arteries in vitro.

A Miyamoto1, T Obi, A Nishio.   

Abstract

The vasomotor effects of 5-hydroxytryptamine (5-HT) on isolated equine basilar arteries were studied. 5-HT induced contractions of equine basilar arteries in a concentration-dependent manner, with a pEC50 value (with 95% confidence limits) of 7.35 (7.08-7.62). Similar results were obtained with endothelium-denuded basilar arteries. Contractions were not competitively inhibited by the 5-HT2 receptor antagonist ketanserin at low concentrations of 5-HT. Conversely, at high concentrations of 5-HT, contractions were inhibited by ketanserin in a concentration-dependent manner, with a pA2 value of 8.91 (8.62-9.20). The 5-HT1 and 5-HT2 receptor antagonist methiothepin shifted the concentration-response curve of 5-HT downwards and to the right in a concentration-dependent manner. In the presence of 10(-6) mol/L ketanserin, however, methiothepin antagonized 5-HT-induced contractions competitively with a pA2 value of 7.95 (7.59-8.31). The 5-HT3 receptor antagonist MDL 72222 had no effect on 5-HT-induced contractions. The findings of this study indicate that 5-HT1 and 5-HT2 receptors are located in equine basilar arterial smooth muscle cells, and that stimulation of these receptors results in contraction.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8693702     DOI: 10.1007/bf00346578

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  21 in total

1.  Characterization of 5-HT receptors mediating contraction of canine and primate basilar artery by use of GR43175, a selective 5-HT1-like receptor agonist.

Authors:  H E Connor; W Feniuk; P P Humphrey
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

Review 2.  5-HT2 receptor antagonists and migraine therapy.

Authors:  E J Mylecharane
Journal:  J Neurol       Date:  1991       Impact factor: 4.849

3.  Pharmacological characterisation of postjunctional 5-HT receptors in cerebral arteries from the sheep.

Authors:  A J Gaw; R M Wadsworth; P P Humphrey
Journal:  Eur J Pharmacol       Date:  1990-04-10       Impact factor: 4.432

4.  Evidence for two populations of 5-hydroxytryptamine receptors in dog basilar artery.

Authors:  M Frenken
Journal:  J Pharmacol Exp Ther       Date:  1989-07       Impact factor: 4.030

5.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

6.  Endothelium-dependent contractile responses to 5-hydroxytryptamine in the rabbit basilar artery.

Authors:  J M Seager; A H Clark; C J Garland
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

Review 7.  Platelets and coagulation.

Authors:  K Meyers; K J Wardrop
Journal:  Adv Vet Sci Comp Med       Date:  1991

Review 8.  International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).

Authors:  D Hoyer; D E Clarke; J R Fozard; P R Hartig; G R Martin; E J Mylecharane; P R Saxena; P P Humphrey
Journal:  Pharmacol Rev       Date:  1994-06       Impact factor: 25.468

9.  Evidence that 5-HT2 receptors predominantly mediate the contraction of the rat basilar artery to 5-hydroxytryptamine.

Authors:  V Deckert; J A Angus
Journal:  Eur J Pharmacol       Date:  1992-10-06       Impact factor: 4.432

10.  Nerves containing serotonin, its interaction with noradrenaline, and characterization of serotonin receptors in cerebral arteries of monkey.

Authors:  J Y Chang; J E Hardebo; C Owman; C Sahlin; N A Svendgaard
Journal:  J Auton Pharmacol       Date:  1987-12
View more
  1 in total

1.  Vasomotor effects of 5-hydroxytryptamine, histamine, angiotensin II, acetylcholine, noradrenaline, and bradykinin on the cerebral artery of bottlenose dolphin (Tursiops truncatus).

Authors:  Md Zahorul Islam; Yuji Sawatari; Shusuke Kojima; Yusuke Kiyama; Moe Nakamura; Kyouko Sasaki; Mika Otsuka; Takeshi Obi; Mitsuya Shiraishi; Atsushi Miyamoto
Journal:  J Vet Med Sci       Date:  2020-08-19       Impact factor: 1.267

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.